Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics

Biorheology

Volumn 46, Issue 3, 2009, Pages 207-225

  Thomas, Susan N ^a   Tong, Ziqiu ^a   Stebe, Kathleen J ^a,b   Konstantopoulos, Konstantinos ^a  

^a Johns Hopkins University   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adhesion; Carcinoembryonic antigen; CD44v; Microcontact printing; Microfluidics; Podocalyxin like protein; Selectins; Soft lithography

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD44V ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GOLD NANOPARTICLE; L SELECTIN; LIGAND; PADGEM PROTEIN; PODOCALYXIN; QUANTUM DOT; SELECTIN;

CANCER DIAGNOSIS; CELL ADHESION; CELL SELECTION; COLON CANCER; HOST CELL; METASTASIS; MICROFLUIDIC ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR CELL;

ANTIGENS, CD44; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION; COLONIC NEOPLASMS; HUMANS; LIGANDS; MICROFLUIDICS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; SELECTINS; SIALOGLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 68649116519     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: 10.3233/BIR-2009-0534     Document Type: Review

References (119)

1. W.T. Al-Jamal, K.T. Al-Jamal, P.H. Bomans, P.M. Frederik and K. Kostarelos, Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer, Small 4 (2008), 1406-1415.
2. X. Banquy, G. Leclair, J.-M. Rabanel, A. Argaw et al., Selectins ligand decorated drug carriers for activated endothelial cell targeting, Bioconjugate Chem. 19 (2008), 2030-2039.
3. N. Bao, Y. Zhan and C. Lu, Microfluidic electroporative flow cytometry for studying single-cell biomechanics, Anal. Chem. 80 (2008), 7714-7719.
4. N. Beauchemin, P. Draber, G. Dveksler, P. Gold et al., Redefined nomenclature for members of the carcinoembryonic antigen family, Exp. Cell Res. 252 (1999), 243-249.
5. A. Bernard, J.P. Renault, B. Michel, H.R. Bosshard and E. Delamarche, Microcontact printing of proteins, Adv. Mater. 12 (2000), 1067-1070.
6. R.D. Blumenthal, L. Osorio, M.K. Hayes, I.D. Horak et al., Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft, Cancer Immunol. Immun. 54 (2005), 315-327.
7. L. Borsig, R. Wong, J. Feramisco, D.R. Nadeau et al., Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis, PNAS USA 98 (2001), 3352-3357.
8. L. Borsig, R. Wong, R.O. Hynes, N.M. Varki and A. Varki, Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis, PNAS USA 99 (2002), 2193-2198.
9. M.P. Bos, M. Kuroki, A. Krop-Watorek, D. Hogan and R.J. Belland, CD66 receptor specificity exhibited by neisserial Opa variants is controlled by protein determinants in CD66 N-domains, PNAS USA 95 (1998), 9584-9589.
10. P. Brodt, L. Fallavollita, R.S. Bresalier, S. Meterissian et al., Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis, Int. J. Cancer 71 (1997), 612-619.
11. M.M. Burdick and K. Konstantopoulos, Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow, Am. J. Physiol. Cell Physiol. 287 (2004), C539-C547.
12. E. Camerer, A.A. Qazi, D.N. Duong, I. Cornelissen, R. Advincula and S.R. Coughlin, Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis, Blood 104 (2004), 397-401.
13. C.S. Chen, M. Mrksich, S. Huang, G.M. Whitesides and D.E. Ingber, Geometric control of cell life and death, Science 276 (1997), 1425-1428.
14. A.M. Cleton-Jansen, E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?, Breast Cancer Res. 4 (2002), 5-8.
15. R.S. Cotran, M.A. Gimbrone Jr., M.P. Bevilacqua, D.L. Mendrick and J.S. Pober, Induction and detection of a human endothelial activation antigen in vivo, J. Exp. Med. 164 (1986), 661-666.
16. E. Delamarche, A. Bernard, H. Schmid, A. Bietsch et al., Microfluidic networks for chemical patterning of substrates: Design and application to bioassays, JACS 120 (1998), 500-508.
17. C.J. Dimitroff, J.Y. Lee, R.C. Fuhlbrigge and R. Sackstein, A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells, PNAS USA 97 (2000), 13841-13846.
18. C.J. Dimitroff, J.Y. Lee, S. Rafii, R.C. Fuhlbrigge and R. Sackstein, CD44 is a major E-selectin ligand on human hematopoietic progenitor cells, J. Cell Biol. 153 (2001), 1277-1286.
19. C.J. Dimitroff, J.Y. Lee, K.S. Schor, B.M. Sandmaier and R. Sackstein, Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1, J. Biol. Chem. 276 (2001), 47623-47631.
20. R. Doyonnas, D.B. Kershaw, C. Duhme, H. Merkens et al., Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin, J. Exp. Med. 194 (2001), 13-27.
21. I.J. Fidler, The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited, Nat. Rev. Cancer 3 (2003), 453-458.
22. R.C. Fuhlbrigge, S.L. King, C. Dimitroff, T.S. Kupper and R. Sackstein, Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on western blots, J. Immunol. 168 (2002), 5645-5651.
23. S.G. Furness and K. McNagny, Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis, Immunol. Res. 34 (2006), 13-32.
24. C.J. Gannon, C.R. Patra, R. Bhattacharya, P. Mukherjee and S.A. Curley, Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells, J. Nanobiotechnol. 6 (2008), 2.
25. G.J. Gasic, T.B. Gasic and C.C. Stewart, Antimetastatic effects associated with platelet reduction, PNAS USA 61 (1968), 46-52.
26. M. Ghosh, C. Alves, Z. Tong, K. Tettey et al., Multifunctional surfaces with discrete functionalized regions for biological applications, Langmuir 24 (2008), 8134-8142.
27. U. Gunthert, M. Hofmann, W. Rudy, S. Reber et al., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell 65 (1991), 13-24.
28. S. Hammarstrom, The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues, Semin. Cancer Biol. 9 (1999), 67-81.
29. W. Hanley, O. McCarty, S. Jadhav, Y. Tseng et al., Single molecule characterization of P-selectin/ligand binding, J. Biol. Chem. 278 (2003), 10556-10561.
30. W.D. Hanley, M.M. Burdick, K. Konstantopoulos and R. Sackstein, CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity, Cancer Res. 65 (2005), 5812-5817.
31. W.D. Hanley, S.L. Napier, M.M. Burdick, R.L. Schnaar et al., Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells, FASEB J. 20 (2006), 337-339.
32. N. Harada, T. Mizoi, M. Kinouchi, K. Hoshi et al., Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells, Int. J. Cancer 91 (2001), 67-75.
33. N. Hashida, N. Ohguro, N. Yamazaki, Y. Arakawa et al., High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome, Exp. Eye Res. 86 (2008), 138-149.
34. J. Hashino, Y. Fukuda, S. Oikawa, H. Nakazato and T. Nakanishi, Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen, Clin. Exp. Metastasis 12 (1994), 324-328.
35. N. Hayatsu, M.K. Kaneko, K. Mishima, R. Nishikawa et al., Podocalyxin expression in malignant astrocytic tumors, Biochem. Biophys. Res. Commun. 374 (2008), 394-398.
36. L.C. Heukamp, H.P. Fischer, P. Schirmacher, X. Chen et al., Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions, Histopathology 49 (2006), 242-247.
37. M. Hofmann, W. Rudy, M. Zoller, C. Tolg et al., CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines, Cancer Res. 51 (1991), 5292-5297.
38. R. Huang, T.A. Barber, M.A. Schmidt, R.G. Tompkins et al., A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women, Prenatal Diag. 28 (2008), 892-899.
39. Y. Izumi, Y. Taniuchi, T. Tsuji, C.W. Smith, S. Nakamori, I.J. Fidler and T. Irimura, Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells, Exp. Cell Res. 216 (1995), 215-221.
40. S. Jadhav and K. Konstantopoulos, Fluid shear- and time-dependent modulation of molecular interactions between polymorphonuclear leukocytes and colon carcinomas, Am. J. Physiol. Cell Physiol. 283 (2002), C1133-C1143.
41. S. Jadhav, B.S. Bochner and K. Konstantopoulos, Hydrodynamic shear regulates the kinetics and receptor specificity of polymorphonuclear leukocyte - colon carcinoma cell adhesive interactions, J. Immunol. 167 (2001), 5986-5993.
42. S. Jadhav, C.D. Eggleton and K. Konstantopoulos, Mathematical modeling of cell adhesion in shear flow pertinent to inflammation and cancer metastasis, Curr. Pharm. Design 13 (2007), 1511-1526.
43. R. Kammerer and S. von Kleist, CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis, Int. J. Cancer 57 (1994), 341-347.
44. R. Kannagi, Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer, Glycoconjugate J. 14 (1997), 577-584.
45. R. Kannagi, M. Izawa, T. Koike, K. Miyazaki and N. Kimura, Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis, Cancer Sci. 95 (2004), 377-384.
46. G.S. Kansas, Selectins and their ligands: current concepts and controversies, Blood 88 (1996), 3259-3287.
47. S. Karpatkin, E. Pearlstein, C. Ambrogio and B.S. Coller, Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo, J. Clin. Invest. 81 (1988), 1012-1019.
48. P.S. Kaytes and J.G. Geng, P-selectin mediates adhesion of the human melanoma cell line NKI-4: identification of glycoprotein ligands, Biochemistry 37 (1998), 10514-10521.
49. T.W. Kelley, D. Huntsman, K.M. McNagny, C.D. Roskelley and E.D. Hsi, Podocalyxin: a marker of blasts in acute leukemia, Am. J. Clin. Pathol. 124 (2005), 134-142.
50. D.B. Kershaw, S.G. Beck, B.L. Wharram, J.E. Wiggins et al., Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin, J. Biol. Chem. 272 (1997), 15708-15714.
51. H.R. Kim, M.A. Wheeler, C.M. Wilson, J. Iida et al., Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44, Cancer Res. 64 (2004), 4569-4576.
52. Y.J. Kim and A. Varki, Perspectives on the significance of altered glycosylation of glycoproteins in cancer, Glycoconjugate J. 14 (1997), 569-576.
53. Y.J. Kim, L. Borsig, N.M. Varki and A. Varki, P-selectin deficiency attenuates tumor growth and metastasis, PNAS USA 95 (1998), 9325-9330.
54. Y.J. Kim, L. Borsig, H.L. Han, N.M. Varki and A. Varki, Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium, Am. J. Pathol. 155 (1999), 461-472.
55. H. Laubli, J.L. Stevenson, A. Varki, N.M. Varki and L. Borsig, L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest, Cancer Res. 66 (2006), 1536-1542.
56. C.Y. Lee, G.B. Lee, J.L. Lin, F.C. Huang and C.S. Liao, Integrated microfluidic systems for cell lysis, mixing/pumping and DNA amplification, J. Micromech. Microeng. 15 (2005), 1215-1223.
57. W. Lee, S. Lim, B. Choi and J. Choi, Protein array fabricated by microcontact printing for miniaturized immunoassay, J. Microbiol. Biotechnol. 16 (2006), 1216-1221.
58. A. Leppanen, T. Yago, V.I. Otto, R.P. McEver and R.D. Cummings, Model glycosulfopeptides from P-selectin glycopro-tein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin, J. Biol. Chem. 278 (2003), 26391-26400.
59. H.G. Leusch, S.A. Hefta, Z. Drzeniek, K. Hummel et al., Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA), FEBS Lett. 261 (1990), 405-409.
60. F. Li, P.P. Wilkins, S. Crawley, J. Weinsteinm et al., Post-translational modifications of recombinant P-selectin glycopro-tein ligand-1 required for binding to P- and E-selectin, J. Biol. Chem. 271 (1996), 3255-3264.
61. L. Li, H.J. Short, K.X. Qian, A.P. Elhammer and J.G. Geng, Characterization of glycoprotein ligands for P-selectin on a human small cell lung cancer cell line NCI-H345, Biochem. Biophys. Res. Commun. 288 (2001), 637-644.
62. S. Liang and C. Dong, Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions, Am. J. Physiol. Cell Physiol. 295 (2008), C701-C707.
63. K.T. Lim, K. Miyazaki, N. Kimura, M. Izawa and R. Kannagi, Clinical application of functional glycoproteomics -dissection of glycotopes carried by soluble CD44 variants in sera of patients with cancers, Proteomics 8 (2008), 3263-3273.
64. A.W. Lin, N.A. Lewinski, J.L. West, N.J. Halas and R.A. Drezek, Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells, J Biomed Opt. 10 (2005), 064035.
65. J. Ling, Use of quantum dot-conjugated antibodies to study intracellular cancer biomarkers in living and fixed cells, Proc. SPIE 6866 (2008), 68660T-68612T.
66. R.H. Liu, J. Yang, R. Lenigk, J. Bonanno and P. Grodzinski, Self-contained, fully integrated biochip for sample preparation, polymerase chain reaction amplification, and DNA microarray detection, Anal. Chem. 76 (2004), 1824-1831.
67. G. Mannori, P. Crottet, O. Cecconi, K. Hanasaki et al., Differential colon cancer cell adhesion to E-, P-, and L-selectin: Role of mucin-type glycoproteins, Cancer Res. 55 (1995), 4425-4431.
68. G. Mannori, D. Santoro, L. Carter, C. Corless et al., Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin, Am. J. Pathol. 151 (1997), 233-243.
69. J.S. Marcus, W.F. Anderson and S.R. Quake, Microfluidic single-cell mRNA isolation and analysis, Anal. Chem. 78 (2006), 3084-3089.
70. J.L. Marshall, J.L. Gulley, P.M. Arlen, P.K. Beetham et al., Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte- macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas, J. Clin. Oncol. 23 (2005), 720-731.
71. O.J. McCarty, S.A. Mousa, P.F. Bray and K. Konstantopoulos, Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions, Blood 96 (2000), 1789-1797.
72. S. Minami, J. Furui and T. Kanematsu, Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen, Cancer Res. 61 (2001), 2732-2735.
73. H. Mohamed, J.N. Turner and M. Caggana, Biochip for separating fetal cells from maternal circulation, J. Chromatogr. A 1162 (2007), 187-192.
74. S. Nagrath, L.V. Sequist, S. Maheswaran, D.W. Bell et al., Isolation of rare circulating tumour cells in cancer patients by microchip technology, Nature 450 (2007), 1235-1239.
75. S. Nakamori, M. Kameyama, S. Imaoka, H. Furukawa et al., Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study, Cancer Res. 53 (1993), 3632-3637.
76. T. Nakayama, M. Watanabe, T. Katsumata, T. Teramoto and M. Kitajima, Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma, Cancer 75 (1995), 2051-2056.
77. S.L. Napier, Z.R. Healy, R.L. Schnaar and K. Konstantopoulos, Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: The roles of CD44V and alternative sialofucosylated selectin ligands, J. Biol. Chem. 282 (2007), 3433-3441.
78. G.F. Nash, L.F. Turner, M.F. Scully and A.K. Kakkar, Platelets and cancer, Lancet Oncol. 3 (2002), 425-430.
79. S. Nie, Y. Xing, G.J. Kim and J.W. Simons, Nanotechnology applications in cancer, Annu. Rev. Biomed. Eng. 9 (2007), 257-288.
80. B. Nieswandt, M. Hafner, B. Echtenacher and D.N. Mannel, Lysis of tumor cells by natutal killer cells in mice is impeded by platelets, Cancer Res. 59 (1999), 1295-1300.
81. B. Obrink, CEA adhesion molecules: multifunctional proteins with signal-regulatory properties, Curr. Opin. Cell Biol. 9 (1997), 616-626.
82. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, K.W. Kombrinck, M. Jirouskova and J.L. Degen, Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells, Blood 105 (2005), 178-185.
83. C.R. Patra, R. Bhattacharya, E. Wang, A. Katarya et al., Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent, Cancer Res. 68 (2008), 1970-1978.
84. R.J. Paxton, G. Mooser, H. Pande, T.D. Lee and J.E. Shively, Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family, PNAS USA 84 (1987), 920-924.
85. H. Ponta, L. Sherman and P.A. Herrlich, CD44: from adhesion molecules to signalling regulators, Nat. Rev. Mol. Cell Biol. 4 (2003), 33-45.
86. I.B. Prado, A.A. Laudanna and C.R. Carneiro, Susceptibility of colorectal-carcinoma cells to natural-killer-mediated lysis: relationship to CEA expression and degree of differentiation, Int. J. Cancer 61 (1995), 854-860.
87. K. Ropponen, M. Tammi, J. Parkkinen, M. Eskelinenm et al., Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer, Cancer Res. 58 (1998), 342-347.
88. N.L. Rosi and C.A. Mirkin, Nanostructures in biodiagnostics, Chem. Rev. 105 (2005), 1547-1562.
89. H.S. Sakhalkar, M.K. Dalal, A.K. Salem, R. Ansari et al., Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo, PNAS USA 100 (2003), 15895-15900.
90. C. Sassetti, K. Tangemann, M.S. Singer, D.B. Kershaw and S.D. Rosen, Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34, J. Exp. Med. 187 (1998), 1965-1975.
91. M. Sato, T. Narita, N. Kimura, K. Zenita et al., The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells, Anticancer Res. 17 (1997), 3505-3511.
92. W.M. Schopperle, D.B. Kershaw and W.C. DeWolf, Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin, Biochem. Biophys. Res. Commun. 300 (2003), 285-290.
93. S.F. Sener, J.P. Imperato, J. Chmiel, A. Fremgen and J. Sylvester, The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer, CA Cancer. J. Clin. 39 (1989), 50-57.
94. E.L. Simon, H.L. Goel, N. Teider, T. Wang et al., High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression, Prostate 64 (2005), 83-91.
95. N. Sippy, R. Luxton, R.J. Lewis and D.C. Cowell, Rapid electrochemical detection and identification of catalase positive micro-organisms, Biosens. Bioelectron. 18 (2003), 741-749.
96. M.J. Slattery and C. Dong, Neutrophils influence melanoma adhesion and migration under flow conditions, Int. J. Cancer 106 (2003), 713-722.
97. A. Somasiri, J.S. Nielsen, N. Makretsov, M.L. McCoy et al., Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression, Cancer Res. 64 (2004), 5068-5073.
98. J.R. Starkey, H.D. Liggitt, W. Jones and H.L. Hosick, Influence of migratory blood cells on the attachment of tumor cells to vascular endothelium, Int. J. Cancer 34 (1984), 535-543.
99. N. Stern, G. Markel, T.I. Arnon, R. Grudam et al., Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1, J. Immunol. 174 (2005), 6692-6701.
100. J.P. Stone and D.D. Wagner, P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer, J. Clin. Invest. 92 (1993), 804-813.
101. S. Takayama, J.C. McDonald, E. Ostuni, M.N. Liang, et al., Patterning cells and their environments using multiple laminar fluid flows in capillary networks, PNAS USA 96 (1999), 5545-5548.
102. T. Takeda, W.Y. Go, R.A. Orlando and M.G. Farquhar, Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells, Mol. Biol. Cell 11 (2000), 3219-3232.
103. S.N. Thomas, R.L. Schnaar and K. Konstantopoulos, Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: Comparative biochemical properties of selectin ligands in host and tumor cells, Am. J. Physiol. Cell Physiol. 296 (2009), C505-C513.
104. S.N. Thomas, F. Zhu, R.L. Schnaar, C.S. Alves and K. Konstantopoulos, Carcinoembryonic antigen and CD44v cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow, J. Biol. Chem. 283 (2008), 15647-15655.
105. L.M. Tibbetts, C.M. Doremus, G.N. Tzanakakis and M.P. Vezeridis, Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production, Cancer 71 (1993), 315-321.
106. N.C. Tsai and C.Y. Sue, SU-8 based continuous-flow RT-PCR bio-chips under high-precision temperature control, Biosens. Bioelectron. 22 (2006), 313-317.
107. A. Varki, Selectin ligands: will the real ones please stand up?, J. Clin. Invest. 100 (1997), S31-S35.
108. F.M. Watt, P.W. Jordan and C.H. O'Neill, Cell shape controls terminal differentiation of human epidermal keratinocytes, PNAS USA 85 (1988), 5576-5580.
109. G.M. Whitesides, The origins and the future of microfluidics, Nature 442 (2006), 368-373.
110. G.M. Whitesides, E. Ostuni, S. Takayama, X.Y. Jiang and D.E. Ingber, Soft lithography in biology and biochemistry, Annu. Rev. Biomed. Eng. 3 (2001), 335-373.
111. V.J. Wielenga, K.H. Heider, G.J. Offerhaus, G.R. Adolf et al., Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression, Cancer Res. 53 (1993), 4754-4756.
112. C.C. Wu, Y.S. Li, J.H. Haga, R. Kaunas et al., Directional shear flow and Rho activation prevent the endothelial cell apoptosis induced by micropatterned anisotropic geometry, PNAS USA 104 (2007), 1254-1259.
113. Y. Xia and G.M. Whitesides, Soft lithography, Annu Rev. Mater. Sci. 28 (1998), 153-184.
114. L. Yao, J. Pan, H. Setiadi, K.D. Patel and R.P. McEver, Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells, J. Exp. Med. 184 (1996), 81-92.
115. A. Zajac, D. Song, W. Qian and T. Zhukov, Protein microarrays and quantum dot probes for early cancer detection, Colloid. Surface B 58 (2007), 309-314.
116. H. Zhu, J. Yan and A. Revzin, Catch and release cell sorting: electrochemical desorption of T-cells from antibody-modified microelectrodes, Colloid. Surface B 64 (2008), 260-268.
117. J. Zhu, J. Xue, Z. Guo, L. Zhang and R.E. Marchant, Biomimetic glycoliposomes as nanocarriers for targeting p-selectin on activated platelets, Bioconjugate Chem. 18 (2007), 1366-1369.
118. B.L. Ziober, M.G. Mauk, E.M. Falls, Z. Chen et al., Lab-on-a-chip for oral cancer screening and diagnosis, Head & Neck 30 (2008), 111-121.
119. X. Zou, V.R. Shinde Patil, N.M. Dagia, L.A. Smith et al., PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow, Am. J. Physiol. Cell Physiol. 289 (2005), C415-C424.